HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

AuthorsThomas Prébet, Steven D Gore, Sylvain Thépot, Benjamin Esterni, Bruno Quesnel, Odile Beyne Rauzy, François Dreyfus, Claude Gardin, Pierre Fenaux, Norbert Vey
JournalBritish journal of haematology (Br J Haematol) Vol. 157 Issue 6 Pg. 764-6 (Jun 2012) ISSN: 1365-2141 [Electronic] England
PMID22390719 (Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimetabolites, Antineoplastic
  • Azacitidine
Topics
  • Aged
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Azacitidine (analogs & derivatives)
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia, Myeloid, Acute (mortality)
  • Male
  • Myelodysplastic Syndromes (drug therapy, mortality)
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: